CLINIMIX 289 mg/100mL

CLINIMIX 289 mg/100mL is an intravenous injection containing essential amino acids. It is designed to support nutritional needs in patients who cannot consume food orally. This product is manufactured by Baxter Healthcare Corporation in the USA.

CLINIMIX 289 mg/100mL is used to provide essential amino acids to patients who require parenteral nutrition. This intravenous solution is often used in clinical settings where oral intake is not possible or sufficient. It helps maintain proper nutritional balance and supports overall health.

The effects of CLINIMIX 289 mg/100mL are primarily related to its role in providing essential amino acids. Patients may experience improved nutritional status and better overall health when used as directed by a healthcare professional. Common effects include enhanced protein synthesis and support for metabolic processes.

CLINIMIX 289 mg/100mL should be handled with care and administered under medical supervision. It is important to follow proper hygiene practices to prevent contamination. Patients with known allergies to any of the components should avoid using this product. Always consult a healthcare professional before use.

CLINIMIX 289 mg/100mL may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Certain medications, such as those affecting electrolyte balance, may require monitoring when used concurrently with this product.